NCT Number: NCT02111109
An Observational Pilot Study of the Effects of Traumatic Haemorrhagic Shock and Resuscitation on the Microcirculation
Haemorrhage following major trauma is an important preventable cause of death. Those patients who survive may have a prolonged period of debility caused by failure of key body organs. We suspect that an important contributor to this organ failure may be dysfunction in the network of small blood vessels that supply the bodies organs with oxygen and nutrients. Our study will examine the link between the microcirculation and organ failure in patients who have suffered significant bleeding after traumatic injury. We will also explore the relationship between resuscitation of the global circulation (blood pressure, cardiac output etc.)an area that is monitored in clinical practice with the state of the microcirculation, which by contrast is not monitored. Patients with severe traumatic injury commonly have problems with blood clotting. Some researchers have suggested that microcirculatory failure may be an important contributor to this problem and we will explore this in more detail. Finally, we will attempt to examine some of the mechanisms by which the microcirculation may be disrupted by trauma and subsequent bleeding. These may include inappropriate activation of white blood cells, inadequate function of oxygen carrying red blood cells and changes to the cells lining the small blood vessels.
We will use a non invasive method to assess the microcirculation termed Side Stream Dark Field microscopy. This involves recorded a video image of the movement of blood within the small blood vessels under a patients tongue. In addition we will use ultrasound to assess the flow of blood from the heart. Small samples of blood will be taken to assess blood clotting and to look at possible mechanisms of microcirculatory dysfunction.
We aim to study ten patients in the first instance. The study will be carried out within the intensive care units at Kings College Hospital.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
University Hospital Birmingham, Birmingham, West Midlands, United Kingdom
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
History of traumatic injury received blood products prior to ICU admission
Exclusion criteria
Not expected to survive 24 hours
Treatment and study plan
Primary outcomes
-
SOFA score
Time frame: 72 hours
Secondary outcomes
-
Length of ICU stay
Time frame: 28 days
-
Mortality
Time frame: 28 days
Sponsors and collaborators
Lead sponsor
King's College Hospital NHS Trust
Other
Collaborators
- University Hospital Birmingham
Registry information
Acronym: MICROSHOCK
Important dates
- Study start
- 2014
- Primary completion
- 2017
- Study completion
- 2017
- First posted
- Apr 10, 2014
- Registry last updated
- Sep 11, 2019
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Renal Perfusion and the Development of AKI Following Traumatic Injury
NCT06917053
AKI (Acute Kidney Injury) Due to Trauma, AKI - Acute Kidney Injury
London, United Kingdom
View Trial DetailsProving Hemodilution in a Human Model for Class I Hemorrhage
NCT02318355
Hemodilution, Hemorrhage
View Trial DetailsTranexamic Acid Mechanisms and Pharmacokinetics in Traumatic Injury
NCT02535949
Hemorrhage, Pathologic Processes
St Louis, Missouri, United States
View Trial DetailsPragmatic, Randomized Optimal Platelet and Plasma Ratios
NCT01545232
Acute Lung Injury, Cardiovascular Diseases
Birmingham, Alabama, United States
View Trial Details